[8-K] FVCBankcorp, Inc. Reports Material Event

Rhea-AI Filing Summary

Millennium Management LLC and affiliates filed a Schedule 13G disclosing a passive stake in AngioDynamics, Inc. (ANGO). As of 16 Jul 2025 the group beneficially owns between 2.12 M and 2.15 M common shares, equal to ~5.2-5.3 % of the outstanding stock. All voting and dispositive power is reported as shared; no sole authority exists.

The filing covers four reporting persons – Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and founder Israel A. Englander. Each entity is organized in Delaware (Englander is a U.S. citizen) and the shares are held through investment vehicles controlled by Millennium. The group certifies the position was acquired solely for investment purposes and not to influence control of the issuer.

Crossing the 5 % ownership threshold on 07/16/25 triggered the disclosure; a joint filing agreement dated 21 Jul 2025 is included. No purchase prices or additional transaction details are provided.

Positive

• Millennium Management & affiliates now own ~5.3 % of ANGO, adding a high-profile institutional investor that could bolster market confidence and liquidity.

Negative

• None.

Insights

Securities Analyst

TL;DR: Millennium’s 5.3 % passive stake signals institutional confidence but brings limited governance impact.

The 13G reveals Millennium and related vehicles holding ~2.15 M ANGO shares, giving the fund shared voting/dispositive power without activist intent (Form 13G vs. 13D). A respected multi-strategy hedge fund entering the top-holder list can improve liquidity and may be viewed positively by the market, yet ownership remains well below levels that could drive strategic change or board representation. From a valuation standpoint the disclosure is modestly supportive; risk profile and capital structure of AngioDynamics are unchanged.

0001675644FALSE00016756442025-07-222025-07-22

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 22, 2025

FVCBankcorp, Inc.

(Exact name of registrant as specified in its charter)

Virginia			001-38647			47-5020283
(State or other jurisdiction of incorporation)			(Commission file number)			(IRS Employer Number)

11325 Random Hills Road

Fairfax, Virginia 22030

(Address of Principal Executive Offices) (Zip Code)

(703) 436-3800

Registrant’s telephone number, including area code:

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (See General Instruction A.2. below):

¨			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities Registered under Section 12(b) of the Act:

Title of Each Class

Trading Symbol(s)

Name of Each Exchange on Which Registered

Common Stock, $0.01 par value

FVCB

The Nasdaq Stock Market, LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

Item 2.02    Results of Operations and Financial Condition.

On July 22, 2025, FVCBankcorp, Inc. (the “Company”) issued a press release reporting its financial results for the period ended June 30, 2025.  A copy of the press release is being furnished as Exhibit 99.1 to this report and is incorporated by reference into this Item 2.02.

Item 9.01    Financial Statements and Exhibits.

(d)    Exhibits.

Exhibit No.						Description
99.1						Press Release, dated July 22, 2025.
104						The cover page from the Company’s Form 8-K with a date on report of July 22, 2025, formatted in Inline Extensible Business Reporting Language (included with the Inline XBRL document).

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			FVCBANKCORP, INC.
			By:			/s/ Jennifer L. Deacon
						Jennifer L. Deacon, Senior Executive Vice President and Chief Financial Officer
Dated: July 22, 2025

FAQ

What percentage of AngioDynamics (ANGO) shares does Millennium now own?

The group reports beneficial ownership of approximately 5.2-5.3 % of outstanding common stock.

How many ANGO shares are reported in the Schedule 13G?

Millennium affiliates disclose ownership of about 2.12–2.15 million shares.

Is Millennium’s stake considered passive or activist?

The use of Schedule 13G certifies the stake is passive with no intent to influence control.

What is the event date that triggered the 13G filing?

The 5 % threshold was crossed on July 16, 2025.

Who signed the filing on behalf of the reporting entities?

Global General Counsel Gil Raviv signed for the Millennium entities; Israel A. Englander signed individually.